Because CKD prevents hypophosphatemia, the increase in FGF‐23 associated with iron infusion is not followed by hypophosphatemia and osteomalacia associated with hypophosphatemia after repeated iron infusion is not observed. Here, FGF23 is linked to chronic kidney disease.